The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
STAT8d
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...
Daily5d
Tirzepatide taken for weight loss may lead to Colonic Ischemia: Case report
A recent case published in the journal ACG CASE REPORTS JOURNAL found a possible risk of colonic ischemia caused by the usage ...
Lilly’s US weight-loss drug shortage ends, curtailing copycats
Eli Lilly and Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli ...
FDA warns companies over unapproved weight loss drug sales
The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling ...
tyla1d
Elon Musk reveals what he’s used to help new weight loss transformation
Elon Musk has dished the secrets behind his recent weight loss transformation.
AOL2d
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Eli Lilly’s weight loss drug Zepbound is no longer in short ... "FDA has determined that the shortage of tirzepatide injection products, which first began in December 2022, is resolved," the ...